GMP Ancillary Materials for Cell and Gene Therapy Manufacturing
Ancillary materials (AMs), also called raw materials in Europe, are components, reagents, and materials used in the manufacturing of cell, gene, and tissue-engineered (CGT) therapies but are not intended to be present in the final product formulation.
Engineering Adoptive T-Cell Therapy To Overcome Immune Suppression in Ovarian Cancer
In this webinar, Dr. Kristin G. Anderson, Research Associate from the Greenberg lab at the Fred Hutchinson Cancer Research Center, discusses engineering T cells to improve survival in the immunosuppressive tumor microenvironment.
A Successful Journey to Cell Therapy Manufacturing: From Research and Development to Lot-Release
Cell therapy is a transformative cancer treatment that utilizes genetically modified cells from a healthy donor or patient's own immune system to attack cancer cells, but manufacturing these cells represents a major challenge for the industry.
Bringing Life to PK Profiles – In Vivo-Relevance From an In Vitro Environment
In drug development, microphysiological systems (MPS) are utilized to develop in vitro biological models that can generate more physiologically- and human-relevant data.
Advances in Proteomics & Metabolomics 2021 Online Symposium
This online symposium will highlight the latest advances in proteomics and metabolomics research and their applications in modern medicine.
Channelopathies Resolved via Cryo-EM and X-Ray Crystallography
Attend this webinar to learn how Dr. Filip Van Petege's lab is solving crystal structures of isolated RyR domains in wild type and disease mutant forms, exploring excessive phosphorylation of RyRs as well as investigating the mechanical coupling between CaV1.1 and RyR1 in skeletal muscle.